Literature DB >> 2720320

Alcohol sclerotherapy of non-parasitic cysts of the liver.

R Andersson1, B Jeppsson, A Lunderquist, S Bengmark.   

Abstract

Between 1980 and 1987, nine patients with non-parasitic cysts of the liver were treated with computed tomography-guided percutaneous puncture and evacuation of the cyst contents followed by injection of absolute alcohol as a sclerosing agent. During the same period only one patient was treated with surgery. The patients included seven women and two men with a mean age of 62 years. Three patients had a single cyst and six patients had multiple cysts. The size of the largest cysts varied between 5 and 20 cm (mean 10 cm). Patients with multiple liver cysts had repeated punctures and sclerosing procedures (up to eight times); 50-3100 ml of cyst fluid (mean 650 ml) was drained per procedure. One patient had symptoms of moderate alcohol intoxication; otherwise no complications were noted. Follow-up was performed with computed tomography or ultrasonography for 8-54 months (median 18 months). The results have been considered successful in eight out of nine patients who had cyst regression and reduced symptoms. Two patients, however, required additional surgical treatment due to residual and multiple cysts. Computed tomography-guided alcohol sclerotherapy of non-parasitic liver cysts appears to be a safe and effective initial therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720320     DOI: 10.1002/bjs.1800760313

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  15 in total

1.  Laparoscopic treatment of nonparasitic liver cysts: adequate selection of patients and surgical technique.

Authors:  J F Gigot; M Legrand; G Hubens; L de Canniere; E Wibin; F Deweer; M L Druart; C Bertrand; H Devriendt; R Droissart; M Tugilimana; P Hauters; L Vereecken
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

2.  Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease.

Authors:  Julie Benzimra; Maxime Ronot; David Fuks; Mohamed Abdel-Rehim; Annie Sibert; Olivier Farges; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2014-02-22       Impact factor: 5.315

Review 3.  Simple hepatic cysts. First case report of percutaneous drainage and sclerosis with doxycycline, with a review of literature.

Authors:  K Tokunaga; S K Teplick; B Banerjee
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

4.  Hepatic resection for cystic lesions of the liver.

Authors:  J R Madariaga; S Iwatsuki; T E Starzl; S Todo; R Selby; G Zetti
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

5.  Laparoscopic management of symptomatic nonparasitic cysts of the liver. Indications and results.

Authors:  M Morino; M De Giuli; V Festa; C Garrone
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

6.  Massive hepatic cyst presenting as right-sided heart failure.

Authors:  A O'Connor; M Lee; G McEntee; D A McNamara
Journal:  Ir J Med Sci       Date:  2010-01-30       Impact factor: 1.568

Review 7.  Surgical management of polycystic liver disease.

Authors:  Robert T Russell; C Wright Pinson
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

8.  Effects of alcohol injection in rat sciatic nerve as a model for Morton's neuroma treatment.

Authors:  Mathew J Mazoch; Gulraiz A Cheema; Larry J Suva; Ruth L Thomas
Journal:  Foot Ankle Int       Date:  2014-08-05       Impact factor: 2.827

9.  Treatment of symptomatic hepatic cysts by percutaneous instillation of minocycline hydrochloride.

Authors:  N Yamada; H Shinzawa; K Ukai; N Makino; T Matsuhashi; H Wakabayashi; H Togashi; T Takahashi
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

10.  Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts performed with a time of exposure to alcohol of 10 min: initial results.

Authors:  Trond B Larssen; Karen Rosendahl; Arild Horn; Dag K Jensen; Jarle Rørvik
Journal:  Eur Radiol       Date:  2003-09-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.